Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 2
2016 2
2017 3
2018 2
2019 3
2020 7
2021 4
2022 2
2023 8
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Results by year

Filters applied: . Clear all
Page 1
Radiopharmaceuticals for Cancer Imaging and Therapy.
Bormans G, Cleeren F. Bormans G, et al. Among authors: cleeren f. Pharmaceutics. 2023 Aug 31;15(9):2262. doi: 10.3390/pharmaceutics15092262. Pharmaceutics. 2023. PMID: 37765231 Free PMC article.
Design and Challenges of Radiopharmaceuticals.
Vermeulen K, Vandamme M, Bormans G, Cleeren F. Vermeulen K, et al. Among authors: cleeren f. Semin Nucl Med. 2019 Sep;49(5):339-356. doi: 10.1053/j.semnuclmed.2019.07.001. Epub 2019 Jul 20. Semin Nucl Med. 2019. PMID: 31470930 Review.
Bismuth-213 for Targeted Radionuclide Therapy: From Atom to Bedside.
Ahenkorah S, Cassells I, Deroose CM, Cardinaels T, Burgoyne AR, Bormans G, Ooms M, Cleeren F. Ahenkorah S, et al. Among authors: cleeren f. Pharmaceutics. 2021 Apr 21;13(5):599. doi: 10.3390/pharmaceutics13050599. Pharmaceutics. 2021. PMID: 33919391 Free PMC article. Review.
Highlight selection of radiochemistry and radiopharmacy developments by editorial board.
Alves F, Antunes IF, Cazzola E, Cleeren F, Cornelissen B, Denkova A, Engle J, Faivre-Chauvet A, Gillings N, Hendrikx JJMA, Jalilian AR, van der Meulen NP, Mikolajczak R, Neels OC, Pillai MRA, Reilly R, Rubow S, Seimbille Y, Spreckelmeyer S, Szymanski W, Taddei C. Alves F, et al. Among authors: cleeren f. EJNMMI Radiopharm Chem. 2021 Sep 8;6(1):31. doi: 10.1186/s41181-021-00146-9. EJNMMI Radiopharm Chem. 2021. PMID: 34495412 Free PMC article. Review.
Highlight selection of radiochemistry and radiopharmacy developments by editorial board.
Kiss OC, Scott PJH, Behe M, Penuelas I, Passchier J, Rey A, Patt M, Aime S, Jalilian A, Laverman P, Cheng Z, Chauvet AF, Engle J, Cleeren F, Zhu H, Vercouillie J, van Dam M, Zhang MR, Perk L, Guillet B, Alves F. Kiss OC, et al. Among authors: cleeren f. EJNMMI Radiopharm Chem. 2023 Mar 23;8(1):6. doi: 10.1186/s41181-023-00192-5. EJNMMI Radiopharm Chem. 2023. PMID: 36952073 Free PMC article. Review.
Automated GMP compliant production of [18F]AlF-NOTA-octreotide.
Tshibangu T, Cawthorne C, Serdons K, Pauwels E, Gsell W, Bormans G, Deroose CM, Cleeren F. Tshibangu T, et al. Among authors: cleeren f. EJNMMI Radiopharm Chem. 2020 Jan 29;5(1):4. doi: 10.1186/s41181-019-0084-1. EJNMMI Radiopharm Chem. 2020. PMID: 31997090 Free PMC article.
18F-AlF-NOTA-Octreotide Outperforms 68Ga-DOTATATE/NOC PET in Neuroendocrine Tumor Patients: Results from a Prospective, Multicenter Study.
Pauwels E, Cleeren F, Tshibangu T, Koole M, Serdons K, Boeckxstaens L, Dekervel J, Vandamme T, Lybaert W, den Broeck BV, Laenen A, Clement PM, Geboes K, Cutsem EV, Stroobants S, Verslype C, Bormans G, Deroose CM. Pauwels E, et al. Among authors: cleeren f. J Nucl Med. 2023 Apr;64(4):632-638. doi: 10.2967/jnumed.122.264563. Epub 2022 Oct 20. J Nucl Med. 2023. PMID: 36265911 Free article.
Prospective comparison of [18F]AlF-NOTA-octreotide PET/MRI to [68Ga]Ga-DOTATATE PET/CT in neuroendocrine tumor patients.
Boeckxstaens L, Pauwels E, Vandecaveye V, Deckers W, Cleeren F, Dekervel J, Vandamme T, Serdons K, Koole M, Bormans G, Laenen A, Clement PM, Geboes K, Van Cutsem E, Nackaerts K, Stroobants S, Verslype C, Van Laere K, Deroose CM. Boeckxstaens L, et al. Among authors: cleeren f. EJNMMI Res. 2023 Jun 1;13(1):53. doi: 10.1186/s13550-023-01003-3. EJNMMI Res. 2023. PMID: 37261615 Free PMC article.
35 results